Clinical trials
Completed Carcinoma, Renal Cell trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 4 |
| Roswell Park Cancer Institute | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| City of Hope Medical Center | 2 |
| Duke University | 2 |
| Institute of Oncology Ljubljana | 2 |
| M.D. Anderson Cancer Center | 2 |
| Massachusetts General Hospital | 2 |
| South Valley University | 2 |
| St. Joseph's Healthcare Hamilton | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 74 |
| Kidney Neoplasms | 14 |
| Urinary Bladder Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Carcinoma, Hepatocellular | 9 |
| Stomach Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Colonic Neoplasms | 8 |
| Melanoma | 8 |
| Prostatic Neoplasms | 8 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.